184 related articles for article (PubMed ID: 8790372)
21. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
23. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
24. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
Takami T; Kaposi-Novak P; Uchida K; Gomez-Quiroz LE; Conner EA; Factor VM; Thorgeirsson SS
Cancer Res; 2007 Oct; 67(20):9844-51. PubMed ID: 17942915
[TBL] [Abstract][Full Text] [Related]
25. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
26. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
27. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of c-myc mRNA after completion of liver regeneration in transgenic mice expressing hepatocyte growth factor in liver.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):259-68. PubMed ID: 8680795
[TBL] [Abstract][Full Text] [Related]
29. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
Sargent LM; Sanderson ND; Thorgeirsson SS
Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
[TBL] [Abstract][Full Text] [Related]
30. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
Liu P; Zhao Z; Dominique B
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene].
Merle P; Levy R; Vitvitski L; Chevallier M; Buendia MA; Trepo C
Gastroenterol Clin Biol; 1997; 21(6-7):459-65. PubMed ID: 9295972
[TBL] [Abstract][Full Text] [Related]
32. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
Ohgaki H; Sanderson ND; Ton P; Thorgeirsson SS
Cancer Lett; 1996 Aug; 106(1):43-9. PubMed ID: 8827045
[TBL] [Abstract][Full Text] [Related]
33. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.
Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA
J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472
[TBL] [Abstract][Full Text] [Related]
34. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
35. The Met proto-oncogene mesenchymal to epithelial cell conversion.
Tsarfaty I; Rong S; Resau JH; Rulong S; da Silva PP; Vande Woude GF
Science; 1994 Jan; 263(5143):98-101. PubMed ID: 7505952
[TBL] [Abstract][Full Text] [Related]
36. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF
Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829
[TBL] [Abstract][Full Text] [Related]
37. C-myc is required for the G0/G1-S transition of primary hepatocytes stimulated with a deleted form of hepatocyte growth factor.
Skouteris GG; Schröder CH
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):879-86. PubMed ID: 8670166
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor-induced signal transduction in two normal mouse epithelial cell lines.
Johnson M; Kochhar K; Nakamura T; Iyer A
Biochem Mol Biol Int; 1995 Jul; 36(3):465-74. PubMed ID: 7549943
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the cooperative effects of transforming growth factor alpha and c-myc overexpression in rat liver epithelial cells.
Presnell SC; Thompson MT; Strom SC
Mol Carcinog; 1995 Aug; 13(4):233-44. PubMed ID: 7646762
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
